Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Codexis, Inc. (CDXS)

-NasdaqGS
1.75 Down 0.02(1.13%) Apr 17, 3:53PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States - Map
Phone: 650-421-8100
Website: http://www.codexis.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:125

Business Summary 

Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States, Europe, and Asia. It offers Codex Biocatalyst Panels and Kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. The company also provides development services, such as enzyme screening, enzyme optimization, and enzyme services, as well as markets and sells pharmaceutical intermediates and active pharmaceutical ingredients to pharmaceutical companies. In addition, it develops biocatalysts for use in various fine chemicals market segments, including food, animal feed, polymers, flavors and fragrances, and agricultural chemicals. The company sells its products through its direct sales and business development force. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Codexis, Inc.

Corporate Governance 
Codexis, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 10. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 10; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. John J. Nicols , 50
Chief Exec. Officer, Pres and Director
606.00K0.00
Mr. David D. O'Toole , 55
Chief Financial Officer, Principal Accounting Officer and Sr. VP
206.00K0.00
Mr. Douglas T. Sheehy J.D., 47
Chief Admin. Officer, Exec. VP and Gen. Counsel
401.00K0.00
Dr. Alan Shaw Ph.D., 50
Special Advisor
856.00K962.00K
Dr. John H. Grate Ph.D., 61
Chief Science Officer and Sr. VP of Science & Innovation
N/AN/A
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders